Last reviewed · How we verify
FLUTICASONE PROPRIONATE
FLUTICASONE PROPRIONATE is a Small molecule drug developed by University of Dundee. It is currently FDA-approved. Also known as: Treatment.
At a glance
| Generic name | FLUTICASONE PROPRIONATE |
|---|---|
| Also known as | Treatment |
| Sponsor | University of Dundee |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Seal, Stopping Eczema and Allergy Study (PHASE2)
- Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma (PHASE4)
- Fluticasone and Salmeterol in Allergic Rhinitis (PHASE4)
- Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma (PHASE3)
- A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers (PHASE1)
- Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma (PHASE2)
- Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo (PHASE4)
- Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FLUTICASONE PROPRIONATE CI brief — competitive landscape report
- FLUTICASONE PROPRIONATE updates RSS · CI watch RSS
- University of Dundee portfolio CI
Frequently asked questions about FLUTICASONE PROPRIONATE
What is FLUTICASONE PROPRIONATE?
FLUTICASONE PROPRIONATE is a Small molecule drug developed by University of Dundee.
Who makes FLUTICASONE PROPRIONATE?
FLUTICASONE PROPRIONATE is developed and marketed by University of Dundee (see full University of Dundee pipeline at /company/university-of-dundee).
Is FLUTICASONE PROPRIONATE also known as anything else?
FLUTICASONE PROPRIONATE is also known as Treatment.
What development phase is FLUTICASONE PROPRIONATE in?
FLUTICASONE PROPRIONATE is FDA-approved (marketed).
Related
- Manufacturer: University of Dundee — full pipeline
- Also known as: Treatment
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing